Vice President, Early Discovery Chemistry

revolutionmedicines

Redwood City (CA)

Sur place

USD 350 000 - 650 000

Plein temps

14 jours+

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Résumé du poste

Revolution Medicines seeks a Vice President, Early Discovery Chemistry to lead the science and organization for Early Discovery Chemistry and report to the Senior Vice President of Medicinal Chemistry. You will drive strategy, coordinate across discovery teams, and set the direction for novel chemical matter in oncology.

This executive will foster innovation, expand chemical space using AI/ML, automation, and modern screening, and build a high-performing team with budget and talent development

Qualifications

  • PhD in Organic or Medicinal Chemistry is required.
  • 15+ years of industrial drug discovery experience with leadership in Early Discovery or Medicinal Chemistry.
  • Demonstrated success leading programs from concept to lead optimization.

Responsabilités

  • Vision, strategy, leadership: Develop long-term strategy for portfolio expansion and cross-functional alignment.
  • Innovation: Lead innovation across early discovery and medicinal chemistry using AI/ML, automation, and data science to accelerate discovery.
  • Management excellence: Lead a high-performing team with budget responsibility and career development.
  • Cross-functional collaboration: Align with Research, Digital Drug Discovery, and Translational Research to inform priorities.

Connaissances

Vision & leadership
AI/ML for DMTA
Computational design
Data analytics
Cross-functional collaboration
Strategic leadership
Communication skills

Formation

PhD in Organic/Medicinal Chemistry

Description du poste

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

The Vice President, Early Discovery Chemistry will report to the Senior Vice President of Medicinal Chemistry and Screening Platform Technologies and serve as the scientific and organizational leader for Revolution Medicines' Early Discovery Chemistry organization. The role will lead multidisciplinary teams spanning Early Discovery Chemistry, Analytical Chemistry, library sciences, and enabling discovery technologies to drive the identification of novel chemical matter for Revolution Medicines' oncology pipeline.This executive will define and execute the strategy for discovering high-value chemical matter against challenging targets by integrating innovative chemistry, computational design, AI/ML, automation, and modern screening technologies. The organization will expand accessible chemical space, accelerating hit identification, and delivering differentiated chemical matter into Medicinal Chemistry for lead optimization.The successful candidate will establish Early Discovery Chemistry as a center of scientific excellence that continuously advances technologies, capabilities, and workflows to improve the speed, quality, and probability of success of drug discovery across the Revolution Medicines portfolio.

Key responsibilities include driving innovation and advancing screening and synthesis technologies, building capabilities that expand diversity of the chemical space and accelerate the identification of high-value starting points and tools for drug discovery.
  • Vision, strategy, leadership : Collaborate with Research leadership to develop a long-term strategy for portfolio expansion through discovery of inhibitors of frontier oncology targets. Partner with biology and digital drug discovery to harness data analytics at all stages of discovery, and particularly. Provide vision, leadership and drive cross-functional alignment to support a dynamic portfolio of discovery and development stage projects.
  • Innovation : Provide scientific leadership for innovation across early discovery and medicinal chemistry, leveraging advances in AI/ML, data-informed approaches to accelerate DMTA cycles, computational design, data analysis, automation, innovative synthesis and screening approaches, and data science to accelerate discovery and expand access to novel chemical space. Foster a culture of creativity, scientific excellence.
  • Management excellence : Manage a high-performing group with multiple functions. Sustain productivity through strategic hiring, mentoring, and support for individual career growth. Be accountable for an annual budget.
  • Cross-functional collaboration : Position the Early Discovery Chemistry function as a bridge across Research, enabling bench-to-bedside insights. Partner with Medicinal Chemisry, Structural and Molecular Sciences, Digital Drug Discovery, Systems Biology, and Translational Research to identify molecular determinants of response, resistance, and target vulnerability and to inform discovery priorities.
Required Skills, Experience, and Education:
  • Ph.D. in Organic Chemistry, Medicinal Chemistry, or related discipline.
  • 15+ years of industrial drug discovery experience with significant leadership responsibility in Early Discovery or Medicinal Chemistry.
  • Demonstrated success leading programs from target concept through hit identification and into lead optimization.
  • Hit identification; Library design and chemical diversity; Fragment-based drug discovery; Screening technologies; Computationally enabled molecular design.
  • Building and leading multidisciplinary scientific organizations.
  • Strong strategic leadership experience including organizational design, budgeting, hiring, and talent development.
  • Outstanding communication skills with demonstrated ability to influence senior leadership and cross-functional teams.
  • Ability to work in a high-energy, fast-paced, rapidly evolving and scaling company, operating in a highly competitive field.
  • Demonstrated abili
Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Vice President, Early Discovery Chemistry
Vice President, Early Discovery Chemistry

Revolution Medicines, Inc. • San Francisco (CA)

Sur place
USD 294 000 - 367 000
Competitive equity awards
Executive Director, Early Clinical Development
Executive Director, Early Clinical Development

revolutionmedicines • Redwood City (CA)

Sur place
USD 300 000 - 520 000
Vice President, Portfolio Chemistry
Vice President, Portfolio Chemistry

Revolution Medicines, Inc. • Redwood City (CA)

Sur place
USD 294 000 - 367 000
VP, Early Discovery Chemistry & Innovation Leader
VP, Early Discovery Chemistry & Innovation Leader

revolutionmedicines • Redwood City (CA)

Sur place
USD 350 000 - 650 000
Director, Global Insights
Director, Global Insights

revolutionmedicines • États-Unis

Hybride
USD 150 000 - 230 000
VP, Early Discovery Chemistry & Innovation Leader
VP, Early Discovery Chemistry & Innovation Leader

Revolution Medicines, Inc. • San Francisco (CA)

Sur place
USD 294 000 - 367 000
Competitive equity awards
Senior Director, US Medical Affairs Strategy Lead, Gastrointestinal, Oncology and Emerging Indications
Senior Director, US Medical Affairs Strategy Lead, Gastrointestinal, Oncology and Emerging Indications

revolutionmedicines • États-Unis

Sur place
USD 210 000 - 270 000
Senior Director, Toxicology
Senior Director, Toxicology

revolutionmedicines • Redwood City (CA)

Sur place
USD 210 000 - 320 000
Competitive cash compensation
Equity awards
Strong benefits
+1
Associate Director, Computational Chemistry
Associate Director, Computational Chemistry

Revolution Medicines, Inc. • San Francisco (CA)

Sur place
USD 186 000 - 233 000
Principal Product Manager, Chemistry
Principal Product Manager, Chemistry

revolutionmedicines • Redwood City (CA)

Sur place
USD 180 000 - 250 000